Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
RedDress is the developer of ActiGraft, an FDA-cleared regenerative wound care solution based on the companys proprietary patented technology for reproducing the bodys natural ability to heal wounds.
ActiGraft enables healthcare providers to produce, in real-time, in vitro blood clots from a patients whole blood. Once applied, the blood clots serve as a protective covering, biologic scaffold, and wound microenvironment to help promote the bodys natural wound-healing processes.